$10bn Sandoz Business May Be Sold Or Spun As Novartis Weighs Options

Novartis Aims To Provide Update ‘Towards End Of 2022’

Businessman covering his face using a white paper with drawn question mark, like a mask, for hiding his identity. Isolated gray wall background.
Will Novartis spin out or sell Sandoz? • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business